IPHA Innate Pharma
- 2.740
- -0.010-0.36%
Innate Pharma News
6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
6-K: Report of foreign private issuer (related to financial reporting)
6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Innate Pharma | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Innate Pharma | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Innate Pharma | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Innate Pharma | 20-F: Registration statement / Annual report / Transition report
Innate Pharma | 6-K: Report of foreign private issuer (related to financial reporting)
Innate Pharma | 6-K: Report of foreign private issuer (related to financial reporting)
Innate Pharma | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Innate Pharma | 6-K: Report of foreign private issuer (related to financial reporting)
Innate Pharma | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Innate Pharma | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Innate Pharma | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Innate Pharma | 6-K: Report of foreign private issuer (related to financial reporting)
Innate Pharma | 424B5: Prospectus
Innate Pharma | EFFECT: Others
Analysis
Price Target
No Data
